Iradimed Corp (IRMD) financials
Iradimed revenue and earnings by year
Iradimed's revenue was $83.8 million in the fiscal year to December 31, 2025, up 14.4% from the year before. Net income was $22.5 million, 26.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 11.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84 | 73 | 66 | 53 | 42 | 32 | 39 | 30 | 23 | 32 |
| Revenue growth | 14.4% | 11.7% | 23.0% | 27.5% | 31.8% | -17.7% | 26.5% | 31.9% | -29.0% | — |
| Gross profit | 64 | 56 | 50 | 41 | 32 | 24 | 30 | 23 | 18 | 26 |
| Gross margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% | 77.1% | 76.3% | 75.9% | 81.1% |
| Operating income | 26 | 22 | 20 | 16 | 10 | -1 | 9 | 6 | 1 | 11 |
| Operating margin | 31.2% | 30.0% | 30.6% | 29.3% | 23.5% | -2.4% | 22.5% | 19.7% | 5.6% | 33.6% |
| Net income | 22 | 19 | 17 | 13 | 9 | 1 | 10 | 6 | 0 | 7 |
| Net margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% | 25.0% | 20.7% | 2.2% | 22.2% |
| Diluted EPS | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 | $0.11 | $0.78 | $0.52 | $0.04 | $0.60 |
| Free cash flow | 17 | 17 | 5 | 8 | 11 | 5 | 10 | 7 | 3 | 8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open IRMD in Markets.
See also: IRMD valuation and P/E history · IRMD returns
No forecast, no recommendation. This page describes Iradimed Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.